Additional file 1: of Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy Shunsuke Kondo Satoshi Shiba Ryoko Udagawa Yasuaki Ryushima Miho Yano Tomoko Uehara Mihoko Asanabe Kenji Tamura Jun Hashimoto 10.6084/m9.figshare.c.3629429_D1.v1 https://springernature.figshare.com/articles/presentation/Additional_file_1_of_Assessment_of_adverse_events_via_a_telephone_consultation_service_for_cancer_patients_receiving_ambulatory_chemotherapy/4418891 Figure S1. A) Common adverse events reported during consultation. B) Chemotherapy regimens of patients using the telephone consultation service. AC; adriamycin + cyclophosphamide, CBDCA; carboplatin, PTX; paclitaxel, GEM; gemcitabine, CEF; cyclophosphamide + epirubicine + 5-FU, CDDP; cisplatin, BV; bevacizumab. 2015-07-26 05:00:00 Telephone consultation service Ambulatory chemotherapy CTCAE Triage